A detailed history of Principal Financial Group Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 1,451,249 shares of GILD stock, worth $133 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,451,249
Previous 1,392,068 4.25%
Holding current value
$133 Million
Previous $95.5 Million 27.36%
% of portfolio
0.07%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$66.59 - $83.99 $3.94 Million - $4.97 Million
59,181 Added 4.25%
1,451,249 $122 Million
Q2 2024

Jul 29, 2024

SELL
$63.15 - $72.88 $3.9 Million - $4.51 Million
-61,828 Reduced 4.25%
1,392,068 $95.5 Million
Q1 2024

Apr 29, 2024

SELL
$71.58 - $87.29 $404,856 - $493,712
-5,656 Reduced 0.39%
1,453,896 $106 Million
Q4 2023

Feb 07, 2024

SELL
$73.27 - $83.09 $16.1 Million - $18.2 Million
-219,421 Reduced 13.07%
1,459,552 $118 Million
Q3 2023

Nov 02, 2023

BUY
$73.94 - $80.67 $7.97 Million - $8.7 Million
107,844 Added 6.86%
1,678,973 $126 Million
Q2 2023

Aug 07, 2023

BUY
$76.01 - $86.7 $3.09 Million - $3.53 Million
40,682 Added 2.66%
1,571,129 $121 Million
Q1 2023

May 09, 2023

BUY
$77.31 - $88.08 $1.09 Million - $1.24 Million
14,092 Added 0.93%
1,530,447 $127 Million
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $2.22 Million - $3.19 Million
-35,631 Reduced 2.3%
1,516,355 $130 Million
Q3 2022

Nov 09, 2022

BUY
$59.54 - $68.01 $3.56 Million - $4.07 Million
59,861 Added 4.01%
1,551,986 $95.7 Million
Q2 2022

Aug 10, 2022

SELL
$57.72 - $65.01 $1.32 Million - $1.48 Million
-22,809 Reduced 1.51%
1,492,125 $92.2 Million
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $2.37 Million - $2.97 Million
40,869 Added 2.77%
1,514,934 $90.1 Million
Q4 2021

Feb 09, 2022

SELL
$64.88 - $73.64 $2.19 Million - $2.49 Million
-33,814 Reduced 2.24%
1,474,065 $107 Million
Q3 2021

Nov 09, 2021

SELL
$67.69 - $73.03 $512,007 - $552,398
-7,564 Reduced 0.5%
1,507,879 $105 Million
Q2 2021

Aug 10, 2021

BUY
$63.47 - $69.35 $1.38 Million - $1.5 Million
21,687 Added 1.45%
1,515,443 $104 Million
Q1 2021

May 10, 2021

SELL
$60.0 - $68.46 $7.3 Million - $8.33 Million
-121,635 Reduced 7.53%
1,493,756 $96.5 Million
Q4 2020

Feb 08, 2021

SELL
$56.65 - $64.55 $5.42 Million - $6.18 Million
-95,689 Reduced 5.59%
1,615,391 $94.1 Million
Q3 2020

Nov 06, 2020

SELL
$62.1 - $78.08 $5.72 Million - $7.19 Million
-92,092 Reduced 5.11%
1,711,080 $108 Million
Q2 2020

Aug 05, 2020

BUY
$72.34 - $84.0 $2.71 Million - $3.15 Million
37,505 Added 2.12%
1,803,172 $139 Million
Q1 2020

May 12, 2020

BUY
$62.63 - $80.22 $755,818 - $968,094
12,068 Added 0.69%
1,765,667 $132 Million
Q4 2019

Feb 05, 2020

SELL
$61.62 - $67.78 $3.46 Million - $3.81 Million
-56,206 Reduced 3.11%
1,753,599 $114 Million
Q3 2019

Nov 13, 2019

SELL
$62.51 - $69.0 $489,140 - $539,925
-7,825 Reduced 0.43%
1,809,805 $115 Million
Q2 2019

Aug 12, 2019

SELL
$61.87 - $69.38 $2.95 Million - $3.31 Million
-47,716 Reduced 2.56%
1,817,630 $123 Million
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $10.7 Million - $12 Million
-171,449 Reduced 8.42%
1,865,346 $121 Million
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $7.41 Million - $9.67 Million
-122,389 Reduced 5.67%
2,036,795 $127 Million
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $538,021 - $595,688
7,548 Added 0.35%
2,159,184 $167 Million
Q2 2018

Aug 13, 2018

SELL
$64.88 - $75.68 $51.5 Million - $60.1 Million
-793,959 Reduced 26.95%
2,151,636 $0
Q1 2018

May 14, 2018

BUY
$72.84 - $88.8 $10.8 Million - $13.2 Million
148,398 Added 5.31%
2,945,595 $222 Million
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $31.8 Million - $37.3 Million
-447,189 Reduced 13.78%
2,797,197 $200 Million
Q3 2017

Nov 02, 2017

BUY
$72.11 - $85.47 $234 Million - $277 Million
3,244,386
3,244,386 $263 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.